P30274 (CCNA2_BOVIN) Bos taurus (Bovine)

Cyclin-A2 UniProtKBInterProSTRINGInteractive Modelling

430 aa; Sequence (Fasta) ; 4 identical sequences: Bos indicus: A0A6P5BWT7; Bos mutus: A0A6B0RXY5; Bos indicus x Bos taurus: A0A4W2H7M6; Bos mutus grunniens: A0A8B9WPX6

Available Structures

42 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor roscovitine Heteromer
P24941;
169-430
100RRC;SGM;
CDK2/CyclinA in complex with AZD5438 Heteromer
P24941;
169-430
100FB8;
Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor meriolin 3 Heteromer
P24941;
169-430
100MFR;MG;SGM;
Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor variolin B Heteromer
P24941;
169-430
100VAR;MG;SGM;
CDk2/cyclinA in complex with DRB Heteromer
P24941;
169-430
100RFZ;FMT;SGM;
Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor meriolin 5 Heteromer
P24941;
169-430
100MHR;MG;
Structure of Thr 160 phosphorylated CDK2/cyclin A in complex with the inhibitor N-&-N1 Heteromer
P24941;
169-430
100NNN;SGM;
Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor CR8 Heteromer
P24941;
169-430
100RC8;
CDK2/CyclinA in complex with SU9516 Heteromer
P24941;
170-430
100SU9;
CDK2-cyclin A in complex with FragLite 5 Heteromer
P24941;
170-430
100IIS;
CDK2-cyclin A in complex with FragLite 6 Heteromer
P24941;
170-430
100HGQ;
CDK2-cyclin A in complex with FragLite 31 Heteromer
P24941;
170-430
100HHT;
CDK2-cyclin A in complex with FragLite 17 Heteromer
P24941;
170-430
100A1H6Y;
CDK2-cyclin A in complex with FragLite 24 Heteromer
P24941;
170-430
100IT4;
CDK2-cyclin A in complex with FragLite 18 Heteromer
P24941;
170-430
100IJF;
CDK2-cyclin A in complex with FragLite 26 Heteromer
P24941;
170-430
100UUV;
CDK2-cyclin A in complex with FragLite 29 Heteromer
P24941;
170-430
100V3U;
CDK2-cyclin A in complex with FragLite 28 Heteromer
P24941;
170-430
100UUS;
CDK2-cyclin A in complex with FragLite 12 Heteromer
P24941;
170-430
100IJL;
CDK2-cyclin A in complex with FragLite 16 Heteromer
P24941;
170-430
100HH8;
CDK2-cyclin A in complex with FragLite 27 Heteromer
P24941;
170-430
100W3A;
CDK2-cyclin A in complex with FragLite 20 Heteromer
P24941;
170-430
100IJU;
CDK2-cyclin A in complex with FragLite 30 Heteromer
P24941;
170-430
100W3D;
CDK2-cyclin A in complex with FragLite 14 Heteromer
P24941;
170-430
100HGW;
CDK2-cyclin A in complex with FragLite 22 Heteromer
P24941;
170-430
100UUG;
CDK2-cyclin A in complex with FragLite 1 Heteromer
P24941;
170-430
100BYZ;
Structure of Thr 160 phosphorylated CDK2/cyclin A in complex with the inhibitor NU6271 Heteromer
P24941;
170-430
99.62NU5;
CDK2/CyclinA in complex with Flavopiridol Heteromer
P24941;
170-430
100F9Z;
CDK2-cyclin A in complex with FragLite 8 Heteromer
P24941;
170-430
100T5G;
CDK2-cyclin A in complex with FragLite 7 Heteromer
P24941;
170-430
100HHQ;
CDK2-cyclin A in complex with FragLite 9 Heteromer
P24941;
170-430
100A1H6X;
CDK2/CyclinA in complex with CGP74514A Heteromer
P24941;
170-430
10023D;
CDK2-cyclin A in complex with FragLite 2 Heteromer
P24941;
170-430
100PYZ;EPE;
Cryo-EM structure of CDK2-cyclin A in complex with CDC25A Heteromer
P24941; P30304;
170-430
100
CDK2-cyclin A in complex with FragLite 10 Heteromer
P24941;
170-429
1001P8;
CDK2-cyclin A in complex with FragLite 11 Heteromer
P24941;
170-429
100IJX;
CDK2-cyclin A in complex with FragLite 3 Heteromer
P24941;
170-429
1007ZX;
Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor Heteromer
P24941;
173-430
96.9T6Q;SGM;SO4;
CDK2-cyclin A in complex with FragLite 4 Heteromer
P24941;
170-427
100HEW;
Structure of CDK2/cyclin A in complex with CAN508 Heteromer
P24941;
174-430
100F18;
Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor Heteromer
P24941;
174-429
97.24TJF;
BOVINE CYCLIN A3monomer179-430
99.6

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8bya.1.Bmonomer0.79173-429
90.47